Genesystem Co (XKRX:363250) Treasury Stock : ₩-1,518 Mil (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Genesystem Co Treasury Stock?

Treasury stock is the portion of shares that a company keeps in their own treasury. Genesystem Co's treasury stock for the quarter that ended in Sep. 2024 was ₩-1,518 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.

Genesystem Co Treasury Stock Historical Data

The historical data trend for Genesystem Co's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genesystem Co Treasury Stock Chart

Genesystem Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Treasury Stock

Genesystem Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Treasury Stock	Get a 7-Day Free Trial													-	-	-	-1,517.59	-1,517.59

Genesystem Co Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

Genesystem Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genesystem Co Ltd (XKRX:363250) » Definitions » Treasury Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

200-9, Techno 2-ro, Yuseong-gu, Daejeon, KOR, 34028

Website

http://www.genesystem.co.kr

Genesystem Co Ltd is a biotech engineering company specializing in molecular testing solutions that target on-site testing needs. It develops and markets state-of-the-art PCR platforms as well as related reagents and biochip products designed to enhance the health of human societies and improve the quality of human life.

Genesystem Co Headlines

No Headlines